Cargando…

Development of an Inactivated Vaccine against SARS CoV-2

The rapid spread of SARS-CoV-2 with its mutating strains has posed a global threat to safety during this COVID-19 pandemic. Thus far, there are 123 candidate vaccines in human clinical trials and more than 190 candidates in preclinical development worldwide as per the WHO on 1 October 2021. The vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavel, Shaikh Terkis Islam, Yetiskin, Hazel, Uygut, Muhammet Ali, Aslan, Ahmet Furkan, Aydın, Günsu, İnan, Öznur, Kaplan, Büşra, Ozdarendeli, Aykut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624180/ https://www.ncbi.nlm.nih.gov/pubmed/34835197 http://dx.doi.org/10.3390/vaccines9111266

Ejemplares similares

Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials
por: Ozdarendeli, Aykut, et al.
Publicado: (2023)

Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey
por: Pavel, Shaikh Terkis Islam, et al.
Publicado: (2020)

SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants
por: Mamedov, Tarlan, et al.
Publicado: (2023)

Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model
por: Pavel, Shaikh Terkis Islam, et al.
Publicado: (2020)

Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants
por: Mamedov, Tarlan, et al.
Publicado: (2023)

Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19
por: Mamedov, Tarlan, et al.
Publicado: (2021)

Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice
por: Mamedov, Tarlan, et al.
Publicado: (2021)

Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2
por: Taşlı, Neslihan Pakize, et al.
Publicado: (2022)

Development of a protective inactivated vaccine against Crimean–Congo hemorrhagic fever infection
por: Berber, Engin, et al.
Publicado: (2021)

Crimean–Congo Hemorrhagic Fever Virus: Progress in Vaccine Development
por: Ozdarendeli, Aykut
Publicado: (2023)

Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study
por: Ates, Ihsan, et al.
Publicado: (2023)

A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™)
por: Gül, Fethi, et al.
Publicado: (2022)

Does menopausal status impact urinary continence outcomes following abdominal sacrocolpopexy without anti-incontinence procedures in continent women?
por: Inan, Abdurrahman Hamdi, et al.
Publicado: (2016)

Rapid thermal inactivation of aerosolized SARS-CoV-2
por: Canpolat, Murat, et al.
Publicado: (2022)

Unilateral Axillary Lymphadenopathy after the Inactivated SARS-COV-2 (CoronaVac) Vaccine: Ultrasonographic Imaging
por: Elverici, Eda, et al.
Publicado: (2023)

Immunization of Knock-Out α/β Interferon Receptor Mice against High Lethal Dose of Crimean-Congo Hemorrhagic Fever Virus with a Cell Culture Based Vaccine
por: Canakoglu, Nurettin, et al.
Publicado: (2015)

SARS-COV-2 viral load in tears of patients with COVID-19 in the early symptomatic stages: comparison of two different tear sampling methods
por: Sonmez, A., et al.
Publicado: (2022)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination
por: Aydın, Mehmet Fethullah, et al.
Publicado: (2021)

Role of the coronary and non-coronary cardiovascular findings on non-cardiac gated thoracic CT in predicting mortality in SARS-CoV-2 infection
por: Celik, Aziz Inan, et al.
Publicado: (2022)

The influence of COVID-19 pandemic on intrauterine fetal demise and possible vertical transmission of SARS-CoV-2
por: Öcal, Doğa Fatma, et al.
Publicado: (2022)

Chewable tablet with herbal extracts and propolis arrests Wuhan and Omicron variants of SARS-CoV-2 virus
por: Karaoğlu, Öznur, et al.
Publicado: (2023)

Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus
por: Canakoglu, Nurettin, et al.
Publicado: (2013)

The Seroprevalence of Crimean-Congo Hemorrhagic Fever in Wild and Domestic Animals: An Epidemiological Update for Domestic Animals and First Seroevidence in Wild Animals from Turkiye
por: Nurettin, Canakoglu, et al.
Publicado: (2022)

Sclerosing encapsulated peritonitis: typical imaging findings for easy diagnosis
por: Duman, Emrah, et al.
Publicado: (2018)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 by gamma irradiation
por: Jain, Rajlaxmi, et al.
Publicado: (2021)

Inactivating SARS-CoV-2 by electrochemical oxidation
por: Tu, Yunchuan, et al.
Publicado: (2021)

Assessment of inactivation procedures for SARS-CoV-2
por: Auerswald, Heidi, et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 Laboratory Specimens
por: Haddock, Elaine, et al.
Publicado: (2021)

Inactivation of SARS-CoV-2 by Ozonated Glycerol
por: Takeda, Yohei, et al.
Publicado: (2021)

PMMA Microcapsules for the Inactivation of SARS-CoV-2
por: Sousa, Vânia I., et al.
Publicado: (2022)

Process Development of Fly Ash-Based Geopolymer Mortars in View of the Mechanical Characteristics
por: Öz, Hatice Öznur, et al.
Publicado: (2021)

Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial
por: Omma, Ahmet, et al.
Publicado: (2022)

Growth, detection, quantification, and inactivation of SARS-CoV-2
por: Case, James Brett, et al.
Publicado: (2020)

Propagation, Inactivation, and Safety Testing of SARS-CoV-2
por: Jureka, Alexander S., et al.
Publicado: (2020)

Cold atmospheric plasma for SARS-CoV-2 inactivation
por: Chen, Zhitong, et al.
Publicado: (2020)

Thermal inactivation scaling applied for SARS-CoV-2
por: Seifer, Shahar, et al.
Publicado: (2021)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_231ndl3cdjhrec44okj61qvf34